Subscribe to Newsletter

Glaukos

Our mission is to pioneer and lead the global glaucoma market with micro-scale injectable therapies that advance the existing glaucoma standard-of-care and enrich the lives and treatment alternatives for glaucoma patients worldwide.

Glaukos Corporation
Address:  229 Avenida Fabricante, San Clemente, CA 92672 United States
Phone: +1 949 367 9600

https://www.glaukos.com/en-uk/ 

Content by Glaukos:

Articles

Business & Profession Glaucoma

Instilling an Interventional Glaucoma Mindset

| Sponsored by Glaukos | 6 min read

Six subject matter experts talk about what interventional glaucoma means for the future of patient treatment and care

Subspecialties Glaucoma

A Standalone MIGS Landmark

| Sponsored by Glaukos | 5 min read

The iStent infinite® represents an interventional glaucoma revolution for both surgeons and patients

Subspecialties Glaucoma

iStent Infinite®: The Micro-Invasive Alternative for Interventional Glaucoma

| Julian Upton | 4 min read

How the iStent infinite meets the large unmet need for standalone MIGS implant surgery

Subspecialties Retina

Advancing Innovation in MIGS

| Sponsored by Glaukos | 4 min read

Glaukos’ technology and products continue to transform the way ophthalmic surgeons manage chronic eye diseases

Subspecialties Cataract

Why Quality of Life Matters

| Gok Ratnarajan | 5 min read

Subspecialties Glaucoma

To Infinity… And Beyond

| Sponsored by Glaukos | 2 min read

The new iStent infinite is minimally invasive option for managing glaucoma

Subspecialties Glaucoma

Glaucoma Management: Infinitely Improved

| Sponsored by Glaukos | 2 min read

With two decades of studies behind it, Glaukos’ iStent platform has the longest-term body of evidence of any MIGS procedure

Subspecialties Glaucoma

Kjell Gunnar Gundersen on the iStent inject® W

| Sponsored by Glaukos

How can glaucoma be addressed during cataract surgery?

Subspecialties Comprehensive

ESCRS 2021: An Invite from Glaukos

| Sponsored by Glaukos

Andrew Geddes, Vice President, Commercial – Europe, Middle East & India at Glaukos, talks about the company's plans for this year's ESCRS Meeting

Subspecialties Glaucoma

Two Conditions – One Procedure

| Sponsored by Glaukos

Glaukos’ iStent inject® W is proven to do address cataract and glaucoma at the same time safely and effectively

Webinars on Demand

Subspecialties Glaucoma

Interventional Glaucoma: A Year in Review

| Sponsored by Glaukos

This webinar will explore how the interventional glaucoma mindset has influenced the way we treat patients today.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: